The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.

For those paying the full cost of medications, the new model will reduce the monthly cost for brand-name prescriptions by an ...

The Cigna Group (NYSE:CI) on Thursday reported third-quarter earnings that exceeded analyst expectations, but shares in the global health company fell sharply after CEO David Cordani warned of profit ...

Cigna Group beat Wall Street estimates for third-quarter profit on Thursday, driven by strength in the company's health ...

Cigna Group’s announcement that it will end the highly criticized practice of accepting back-end drug manufacturer rebates ...

The stock market pummeled Cigna after the company revealed its new plan to ditch pharmacy benefit rebates will lower that ...

The Cigna Group recorded $1.87 billion in profit in Q3, beating analysts’ expectations as shares ticked up prior to the ...

The Cigna Group reported third quarter net income of nearly $2 billion despite rising costs in the health plans it sells.

Cigna stock fell after Q3 results showed solid revenue but forecasted margin pressure in its pharmacy benefit services over ...

The Cigna Group is reaffirming its outlook for the year after posting $1.9 billion in profit for the third quarter. | The ...

Overall, Cigna expects earnings to grow next year after posting a solid third quarter. But investments in a new PBM model and ...

Cigna Group logged higher profit and revenue in the third quarter, boosted by continued strength in its pharmacy-benefit ...